ACRO | 用於雙特異性抗體研究異二聚體的CD3蛋白

ACRO | 用於雙特異性抗體研究異二聚體的CD3蛋白

2020.10.19

You don’t want to miss this!

https://files.constantcontact.com/5f3d0cf9401/c9459c89-7166-4bb3-acae-79d28e955688.png

 

Are your CD3 proteins for bispecific antibody research heterodimers?

https://files.constantcontact.com/5f3d0cf9401/9c59500f-e02b-490d-91c3-e235fddcc199.png

https://files.constantcontact.com/5f3d0cf9401/de6aa9a0-36a6-4a90-9a7e-7ad30c2c6084.png

CD3-targeted therapeutic antibody usually recognizes the CD3ε in the heterodimer complex to activate the anti-tumor activity of T cells. However, in the process of recombinant expression, CD3E and CD3D can randomly form incorrect heterogeneous complexes, leading to the loss of bioactivity and high batch-to-batch inconsistency.

ACROBiosystems, has developed a series of confirmed homogeneous CD3δ/CD3ε and CD3γ/CD3ε proteins with good bioactivity.

 1:1 heterodimers verified by nonreductive electrophoresis and MALS

Show good performance in different applications in therapeutic antibody development

 Used for the development of a bispecific antibody in clinical phase successfully

Free sample is available! Try it Now!

Assay Data

 1:1 heterodimer verified by Nonreduction electrophoresis and MALS

https://files.constantcontact.com/5f3d0cf9401/687c3f44-09c7-4a67-9c09-9a744977aef8.png

Fig.1 Human CD3E&CD3D Heterodimer Protein, His Tag&Tag Free (Cat. No. CDD-H52W1) on SDS-PAGE under reducing (R) and non-reducingNRcondition. The purity of the protein was more than 85% and around 35-43 kDa verified by SEC-MALS.

 High bioactivity and batch-to-batch consistency

https://files.constantcontact.com/5f3d0cf9401/fe8e7e1b-57d9-4aca-889a-bc9e558d9e11.png

Fig.2 Immobilized Biotinylated Human CD3E&CD3D Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDD-H82W6) at 1 μg/mL (100 μL/well) on Streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate, can bind Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3) with a linear range of 0.2-6 ng/mL, and batch differences EC50<0.0001 μg/mL.

 Applied for antibody drug development, screening, identification and quality control

https://files.constantcontact.com/5f3d0cf9401/0103a4be-a99f-48d8-99f9-c37793d171c1.png

Fig.3 Bispecific T-cell Engager (CD3 X BCMA) immobilized on CM5 Chip can bind Human CD3E&CD3D Heterodimer Protein, His Tag&Tag Free (Cat. No. CDD-H52W1) with an affinity constant of 31.8 nM as determined in a SPR assay (Biacore T200).

 Applied for clinical PK assay

https://files.constantcontact.com/5f3d0cf9401/6494b8bf-461b-455e-8063-c2b5a9176517.png

Fig.4 Immobilized Human BCMA, His Tag (Cat. No. BCA-H522y) at 2 μg/mL, add increasing concentrations of Bispecific T cell Engager (CD3 X BCMA) in 10% human serum and then add Biotinylated Human CD3E&CD3D. Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDD-H82W6) at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 15 ng/mL.

Product List

https://files.constantcontact.com/5f3d0cf9401/f92c991f-5eb1-4b18-a49c-44d0e2dcb613.png

back-Top
open-line

LINE 線上諮詢

亞旭-LINE-QRcode

掃瞄或手機直接點擊條碼

error: Content is protected !!